Lazard Asset Management
EDIT icon

Lazard Asset Management’s Editas Medicine EDIT Stock Holding History

Lazard Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-76
Closed – – 2367
2024
Q4 		$0 Hold
76
– – ﹤0.01% 2345
2024
Q3 		$0 Sell
76
-128
-63% -$557 ﹤0.01% 2309
2024
Q2 		$0 Sell
204
-2,870
-93% -$16.2K ﹤0.01% 2286
2024
Q1 		$22K Sell
3,074
-1,706
-36% -$14.2K ﹤0.01% 1829
2023
Q4 		$47K Buy
4,780
+185
+4% +$1.62K ﹤0.01% 1901
2023
Q3 		$35K Buy
4,595
+2,062
+81% +$17.7K ﹤0.01% 1952
2023
Q2 		$20K Sell
2,533
-54
-2% -$470 ﹤0.01% 2095
2023
Q1 		$18K Sell
2,587
-2,897
-53% -$25.8K ﹤0.01% 2068
2022
Q4 		$47K Sell
5,484
-4,068
-43% -$44.7K ﹤0.01% 1846
2022
Q3 		$116K Buy
9,552
+873
+10% +$13.6K ﹤0.01% 1415
2022
Q2 		$102K Sell
8,679
-116,226
-93% -$1.56M ﹤0.01% 1497
2022
Q1 		$2.38M Buy
124,905
+34,249
+38% +$637K ﹤0.01% 871
2021
Q4 		$2.41M Buy
90,656
+46,587
+106% +$1.6M ﹤0.01% 902
2021
Q3 		$1.81M Buy
44,069
+2,074
+5% +$114K ﹤0.01% 928
2021
Q2 		$2.38M Buy
41,995
+41,345
+6,361% +$1.53M ﹤0.01% 828
2021
Q1 		$27K Sell
650
-2,451
-79% -$140K ﹤0.01% 1679
2020
Q4 		$217K Buy
+3,101
New +$127K ﹤0.01% 1090
2020
Q3 		– Sell
-79
Closed -$2K – 1638
2020
Q2 		$2K Buy
+79
New +$2.06K ﹤0.01% 1557

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Lazard Asset Management's EDIT Position: Q1 2025 in Review

Lazard Asset Management sold out of Editas Medicine (EDIT) in Q1 2025, closing a stake of 76 shares.

Lazard Asset Management first reported a position in EDIT in Q2 2020 and held it in 18 quarters. The position peaked at $2.41M in Q4 2021. 194 funds tracked by Wall St. Rank hold EDIT as of Q1 2025.

  • Lazard Asset Management reported no remaining Editas Medicine position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 76 Editas Medicine shares in Q1 2025.
  • Lazard Asset Management first reported a position in Editas Medicine in Q2 2020 and held it in 18 quarters.
  • Lazard Asset Management's Editas Medicine position peaked at $2.41M in Q4 2021.
  • 194 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.